|
March 18, 2019: Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: AUGUSTUS Trial: An Open-label, 2 x 2 Factorial, Randomized Trial to |
Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: AUGUSTUS Trial: An Open-label, 2 x 2 Factorial, Randomized Trial to Evaluate the Safety of Apixaban versus Vitamin K Antagonist and Aspirin versus Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome and/or Percutaneous Coronary Intervention: Primary Results of the AUGUSTUS Trial
TBD
[ Download video ] |
|
No comments have been submitted
|